Healthcare -
Biotechnology - NASDAQ - US
$ 2.64
-4.38 %
$ 416 M
Market Cap
5.0
P/E
CTMX - CASH FROM OPERATIONS
Cash from Operations CTMX - CytomX Therapeutics, Inc.
-86.2 M
LAST VALUE
11.78%
2 YEAR CAGR
9.30%
5 YEAR CAGR
-14.01%
10 YEAR CAGR